Saniona AB: Saniona Ion Channel Research Collaboration with Boehringer Ingelheim Reaches Milestone
Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces that its ongoing ion channel research collaboration with Boehringer Ingelheim has advanced to the lead optimization s ...
Boehringer Ingelheim: Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on surv ...
Seeking Alpha22d
CVS, Cigna PBMs targeted as lawmakers criticize new "anti-competitive" move
Established to produce biosimilars against AbbVie’s (ABBV) Humira in partnership with Sandoz (OTCQX:SDZNY) and Boehringer Ingelheim, Cordavis, and Quallent illustrated PBM’s latest attempts to ...
CNN27d
AI helps uncover hundreds of unknown ancient symbols hidden in Peru’s Nazca Desert
The researchers’ findings also shed some light on the symbols’ enigmatic purpose. Located 50 kilometers (31 miles) inland from Peru’s south coast, the huge symbols were found in the desert ...
Pharmaceutical Technology28d
Boehringer Ingelheim opens $66.8m new cancer research facility
The Angelika Amon research building is named after a Viennese pioneer in cell biology who was closely connected with Boehringer Ingelheim. Image credit: Boehringer Ingelheim. Boehringer Ingelheim has ...